None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Newborns at or above 35 weeks gestation with pre-discharge TSB level placing the newborn in high-intermediate and low-intermediate risk zone. 2 Parent or legal guardian who provide informed consent for their baby participation in the study
Exclusion criteria
Exclusion criteria: 1 Newborn below 35 weeks gestation 2 Newborn with contraindication to phototherapy 3 Newborns with co-morbidities other than hyperbilirubinemia 4 Parents or legal Guardian who do not provide consent for their baby participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The endpoint of the study is the completion of the usability assessment and filling of the questionnaires by the neonatologists, nurses and the parents/legal guardians. Timepoint: 2-5 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 Duration of phototherapy required to achieve clinically acceptable bilirubin levels for stopping phototherapy. 2 Adherence to using the phototherapy romper during kangaroo mother care and feeding periods. Timepoint: 2-5 days | — |
Countries
India
Contacts
Hindusthan hospitals